Dr Marcoux at podium with slide in background

Summary of recommendations from the paper

Screenshot of authorship

Dr. Veronica Marcoux presents official Canadian Thoracic Society position statement

“Infection screening before starting immunosuppression in interstitial lung disease” 🫁

Addressing MTB, HIV, HBV, HCV & strongyloides

@veronicasam940.bsky.social 👏
#OpenAccess

www.tandfonline.com/doi/full/10....

Older men with a microphone 🎤

Stop pointing out how many women are speaking at a conference.
It’s not novel or noteworthy.
It should be standard in 2026.

Developing a vaccine strategy to prevent the progression of pulmonary fibrosis - Nature Immunology Pulmonary fibrosis is an incurable chronic, progressive disease characterized by the emergence of fibrosis-specific cells, including a subset of fibroblasts. Proof-of-concept experiments in mice now s...

Can we develop a vaccine to prevent pulmonary fibrosis? I’d love to think we could. Interested to know what others think. @kaminskimed.bsky.social @kerrijohannson.bsky.social @pulmonaryfibrosis.bsky.social @actionpfcharity.bsky.social

www.nature.com/articles/s41...

The scientific news Antivexers in our gov do not want you to see.
Maternal RSV vax protects of newborn infants‼️
Great to see a gov health agency doing its job without being harassed by charlatans, grifters, eugenicists.
👏🏼UKHSA👏🏼
#VaccinesWork
www.gov.uk/government/n...

Check out the American Thoracic Society at #CRC2026! ❤️🇨🇦 Irina Petrache, MD, ATSF, immediate-past president of the ATS, presented on international perspectives, and along with ATS CEO Karen Collishaw, MPP, connected with leaders in health care and respiratory medicine from around the world.

@drdayjee.bsky.social
@ipfdoc.bsky.social
@rachelkputman.bsky.social
@kaminskimed.bsky.social
@scottmatsonmd.bsky.social
@ats-clinicalprobs.bsky.social
@tkulkarni.bsky.social

How to Develop Your ATS Document Proposal YouTube video by American Thoracic Society

Have you ever wanted to write an official ATS clinical practice guideline or technical statement or workshop report but didn’t know where to start?

Then THIS podcast is for you! 🤩
Just out from @ats-clinicalprobs.bsky.social
@ats-assemblies.bsky.social

youtu.be/7DIJRdQDu2o?...

Screen shot of study title and authors

The most impactful clinical ILD study in ages! 🌟
True multidisciplinary collaboration driving progress 🫁
@rogerjlewis.bsky.social @ipfdoc.bsky.social

A Statistical Model for Lung Function Trajectory and Mortality in Patients with Fibrotic ILD

academic.oup.com/ajrccm/advan...
#OpenAccess

I thought he was playing golf?

Multidisciplinary Videoconferencing for Physician Education and Remote Management of Interstitial Lung Disease
@atscommunity.bsky.social #medsky

🔗 tinyurl.com/2cjt69hv

I wonder how much of my life has been wasted resetting passwords! 😫😫

@delanghelab.bsky.social @tatalab-duke.bsky.social @ipfdoc.bsky.social @kottond.bsky.social @msbr89.bsky.social @varelaslab.bsky.social @lisyvila.bsky.social @carolavoss.bsky.social Please reshare! Thank you :)

Time to stop publishing conference abstracts as AI will not distinguish quality between published abstract and published original research? @atsblueeditor.bsky.social @bmj.com

Indeed as if by magic this person/group/bot posted a heartwarming story about Ivy decontaminating mold spores. Trouble is beyond a 1993 abstract this was NEVER published in JACI, therefore heartwarming but probably wrong. DO NOT trust sources that can not be independently verified. Also…

@kaminskimed.bsky.social @kerrijohannson.bsky.social @charlottesummers.bsky.social

AI Is Inventing Academic Papers That Don't Exist -- And They're Being Cited in Real Journals Academic articles from authors using large language model are creating an ecosystem of fake research that threatens human knowledge itself.

www.rollingstone.com/culture/cult...

Is this the unavoidable endpoint when knowledge, ego and career converge? This is a chilling article which clearly needs the academic community to find a solution, but we need to rethink how we reward academic endeavour. #NoMorePublishOrPerish

Wow! As somebody who shares your rabies paranoia that is a pretty low bar for ruling out infectious causes of sudden death and harvesting lungs. 😳

Thank you so much for your hospitality @kaminskiMed. It was wonderful to interact with so many smart, talented and enthusiastic investigators and experience what an amazing environment you get to live and work in.

Oh no - now I gotta go 👔shopping! 😂 Maybe I’ll bring a tie?! 🤔😂

Would be lovely to get your perspective.

You are too kind!

Oh yes! 😂😂

One of the greatest shows on TV ever. I was particularly amused by the interpretation of the carrot and stick approach. 😂

The most exciting papers of the year! Could these observers provide insights into the potential of immunotherapy in other conditions? 🤔

This is a really great thread 🧵 about an important study using mixed methodology to understand a subject that rarely gets the attention it deserves. Kudos to the team @ucalgary.bsky.social guided by the brilliant @kerrijohannson.bsky.social

Would be fascinating to do an SR+MA on AF as co-meds in trials vs IMP in trials? 🤔

For sure there is no dose response really for Pirfenidone some dose response for nintedanib but really good point!

No, in London.

However, another study highlighting the disappearing treatment effect! Check the placebo vs Pirfenidone groups! 😳😳 we really need better drugs to #CureIPF

TETON-2 data looking good! 96ml of FVC ‘saved’ by inhaled treprostinil at 12 months. Devil will be in detail but all very promising.